In C. elegans, MSPs function as secreted hormones that bind to Eph receptors and unidentified receptors to trigger oocyte maturation. Human VAPB, Drosophila VAP33, and C. elegans VPR-1 are homologous proteins called VAPs with an N-terminal MSP domain and a C-terminal transmembrane domain. A missense mutation (P56S) in the VAPB MSP domain is associated with amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA), but the function of VAP proteins is not understood. Recently, we showed that VAP MSP domains are cleaved and secreted ligands for Eph receptors (Tsuda et al. 2008). The human VAPB MSP domain is present in blood serum and the P56S mutation prevents secretion in fly cells. These data suggest that VAPB proteins have a signaling function that is relevant to ALS pathogenesis. There is increasing evidence that ALS is a systemic disorder, as patients and mouse models can exhibit mitochondrial abnormalities inside and outside of the CNS, insulin resistance, dyslipidemia, and defective energy homeostasis. We show that in C. elegans and Drosophila loss of VAPs causes muscle mitochondrial defects, which can be rescued by VAP expression specifically in neurons. Genetic, biochemical, and molecular studies demonstrate that mitochondria from vap mutants have impaired respiration. These data support the hypothesis that VAP proteins are secreted signals that regulate mitochondrial function. However, Eph receptor mutants do not have mitochondrial defects. To identify new MSP domain receptors, we used a fluorescent binding assay. We show that MSP and VAP MSP domains bind to Roundabout (Robo) receptors, which are broadly expressed in neurons, muscle, and likely oocytes.
sax-3 Robo is required for muscle mitochondrial function and
vpr-1 and
sax-3 act in the same genetic pathway. In addition to mitochondrial defects, loss of C. elegans
vpr-1 causes defects consistent with impaired insulin signaling, including fat accumulation in the intestine and body wall muscle that is dependent on DAF-16/FOXO activity. The increased DAF-16 activity in
vpr-1 mutants appears to be part of a compensatory mechanism. Loss of the
vab-1 Eph receptor, a VPR-1 receptor, causes mild fat metabolism defects. Finally,
vpr-1 mutants are sterile and neuronal overexpression can partially rescue these defects in some animals and cause germline tumors in others. Collectively, our data support a model in which VAPs are components of a neuroendocrine signaling mechanism that controls metabolism and energy homeostasis.